a randomized phase II study testing for optimal strategy for patients with high risks rectal cancer

作者:Vuong T; Kavan P; Martin A G; Azoulay L; Donath D; Lavoie C; Ferland E; Nguyen N; Vasilevsky C A; Desgroseilliers S; Drolet S; Richard C; Boutros M; Batist G
来源:37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 2018-04-20 To 2018-04-24.
DOI:10.1016/S0167-8140(18)30589-9
  • 出版日期2018-4
  • 单位McGill

全文